Mandrake Bio
PrivateLast Round
Pre Seed
Jul 16, 2026
Total Funding Raised
$1.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Mandrake Bio is a biotechnology company that develops AI-powered protein design and gene-editing platforms for agricultural and medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mandrake Bio Comparables
Compare Mandrake Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Basecamp Research | 79% | |
| Profluent Bio | 79% | |
| Biomatter | 77% |
Mandrake Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 16, 2026 |
Mandrake Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DeVC | Pre Seed |
| Activate | Pre Seed |
| Antler India | Pre Seed |
| Antler | Pre Seed |
| Spectrum Impact | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$1.9M round led by Activate and Antler
- May 15, 2026
Grew 75% QoQ, from 4 to 7 employees.
Recent news
Latest coverage and updates
- is_developingJul 16, 2026
Mandrake Bio is developing programmable gene-editing enzymes on Jul 1st '25.
- receives_financingJul 16, 2026
Mandrake Bio received financing of $1.66M in Pre Seed on Jul 16th '26.
Mandrake Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mandrake Bio's valuation, stock price, and market status.
Is Mandrake Bio a public or private company?
Mandrake Bio is a private company.
What is the current stock price of Mandrake Bio?
Mandrake Bio is a private company with no public stock price. Caplight tracks Mandrake Bio's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Mandrake Bio worth (valuation)?
Valuation information for Mandrake Bio is not publicly available.
Can I buy Mandrake Bio stock?
Mandrake Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mandrake Bio's last funding round?
Mandrake Bio's most recent funding round was Pre Seed on July 16, 2026.
Who are the main investors in Mandrake Bio?
Key investors in Mandrake Bio include Activate, Antler.
Will Mandrake Bio IPO soon?
No public IPO plans have been announced for Mandrake Bio.
How can I track Mandrake Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mandrake Bio's secondary market activity and sign up for updates.